The pulmonary involvement in RA may vary, including
interstitial lung disease (ILD), pleural disease, rheumatoid nodules, bronchiectasis, and vasculitis.
Despite the advancements in medicine that have occurred at an unprecedented pace in the 21st century, there has not been a similar level of improvement in the treatment of
interstitial cystitis/bladder pain syndrome (IC/BPS), causing continuing disappointment among both physicians and patients.
Interstitial Cystitis or Bladder Pain Syndrome (IC/BPS) is a chronic bladder condition that consists of discomfort or pain in the bladder or surrounding pelvic region and is often associated with frequent urination.
(1)
Interstitial abnormalities in a probable UIP pattern are primarily reticular opacities, with peripheral traction bronchiectasis or bronchiolectasis with a predominantly basal and subpleural, and often heterogeneous, distribution.
Patients with a history of pulmonary neoplasia or other causes of
interstitial fluid, such as asthma or pulmonary edema and history of smoking were excluded from the study.
[2] The
interstitial pregnancy occurs in this site.
Three years previously, she was first suggested to have
interstitial pneumonia on health checkup.
IC/BPS specific symptoms were evaluated by the validated ICSI (
Interstitial Cystitis Symptom Index), ICPI (
Interstitial Cystitis Problem Index) (23), PUF (Pelvic Pain and Urgency/Frequency Patient Symptom Scale) (24), NRS pain, NRS urgency, NRS frequency scores.
Histological characterization of tubular
interstitial nephritis includes inflammatory changes in the tubulointerstitial compartment, such as leukocyte infiltration, atrophy, accumulation of extracellular matrix proteins, tubular dilation, and
interstitial edema.
All patients with connective tissue disease (CTD) had their diagnoses confirmed by an immunology/rheumatology specialist, and a total of 50 patients with connective tissue disease-associated
interstitial lung disease (CTD-ILD) were observed.